#190 Co-Founder Cost Plus Drugs, Mark Cuban: Mavs to Meds
Grit13 Touko 2024

#190 Co-Founder Cost Plus Drugs, Mark Cuban: Mavs to Meds

Guest: Mark Cuban, co-founder of Cost Plus Drugs and costar, Shark Tank

“I just love to compete,” says Mark Cuban. “And the day I stop is the day I’m dead.” Previously the co-founder of MicroSolutions and Broadcast.com, Cuban is probably best known to the public today for competing with the likes of Daymond John and Barbara Corcoran on the reality TV show Shark Tank. But his real focus — and his real enemy — these days is the pharmaceutical industry. His latest company, Cost Plus Drugs, aims to be far more transparent than established PBMs, or Pharmacy Benefit Managers, and Mark clearly relishes eating their margin. “Everybody talks about disrupting healthcare,” he says. “This is the easiest motherf**king industry I've ever tried to disrupt because it is so opaque, and everybody is so captured by the scale of these big companies.”

In this episode, Mark and Joubin discuss Luka Dončić, Synthesia, the Sony hack, the American Dream, TikTok propaganda, MicroSolutions, throwing away watches, keeping kids grounded, Black Mirror, keeping up, Ali Ghodsi, the NBA, MGM, gambling in Dallas, the Adelson family, CES, transparency, and Alex Oshmyansky.

Chapters:

  • (00:55) - Game day and superstitions
  • (03:08) - Email responsiveness
  • (05:48) - Shark Tank
  • (09:21) - Retiring young
  • (10:57) - American Airlines’ lifetime pass
  • (12:55) - Sports and blue-collar work
  • (16:02) - Compete or die
  • (17:43) - Why Mark hates meetings
  • (19:57) - Immortality through AI
  • (23:05) - The new AI wave
  • (25:07) - Startup founders and low-hanging fruit
  • (29:24) - Selling Broadcast.com to Yahoo
  • (31:35) - The Dallas Mavericks
  • (34:52) - Selling his majority stake
  • (37:08) - The missing link in pharma
  • (41:27) - Disrupting a huge industry
  • (43:57) - The problem with debt
  • (44:59) - What “grit” means to Mark


Links:

Jaksot(279)

#174 CEO & Co-Founder Ginkgo Bioworks, Jason Kelly: Life Finds a Way

#174 CEO & Co-Founder Ginkgo Bioworks, Jason Kelly: Life Finds a Way

Guest: Jason Kelly, CEO and co-founder of Ginkgo BioworksAlmost everyone in the second generation of biotechnology entrepreneurs, says Ginkgo Bioworks CEO Jason Kelly, works in that field because of o...

22 Tammi 202459min

#173 Author of “The Qualified Sales Leader,” John McMahon: The Five-Time CRO

#173 Author of “The Qualified Sales Leader,” John McMahon: The Five-Time CRO

Guest: John McMahon, author of The Qualified Sales Leader: Proven Lessons from a Five Time CROA hell of a lot of people work in sales. But until recently, says five-time CRO and The Qualified Sales Le...

15 Tammi 20241h 33min

#172 Professor at UPenn & Author, Angela Duckworth: Grit

#172 Professor at UPenn & Author, Angela Duckworth: Grit

Guest: Angela Duckworth, professor at the University of Pennsylvania and author of Grit: The Power of Passion and Perseverance“There’s got to be a cost” when you pursue your passions, says University ...

8 Tammi 20241h 11min

#171 Founder & Former CEO Drift, David Cancel: Never Trapped

#171 Founder & Former CEO Drift, David Cancel: Never Trapped

Guest: David Cancel, founder and former CEO of Drift; founder of ReyAfter HubSpot acquired his company Performable in 2011, David Cancel became his acquirer’s Chief Product Officer — and didn’t give a...

1 Tammi 20241h 13min

#170 Chairman of Kleiner Perkins, John Doerr: Getting Into Trouble with Disruptors (Encore)

#170 Chairman of Kleiner Perkins, John Doerr: Getting Into Trouble with Disruptors (Encore)

Guest: John Doerr, chairman of Kleiner PerkinsAfter Kleiner Perkins chairman John Doerr first invested in Google — $12.8 million for 13 percent of the company — he told co-founders Larry Page and Serg...

25 Joulu 20231h 6min

#169 CEO & Founder Cato Networks, Shlomo Kramer: The Burden of Persona

#169 CEO & Founder Cato Networks, Shlomo Kramer: The Burden of Persona

Guest: Shlomo Kramer, founder and CEO of Cato NetworksShlomo Kramer has founded three companies to date — Check Point, Imperva, and most recently Cato Networks — and taken the first two public, with p...

18 Joulu 20231h 2min

#168 CEO & Founder Glean, Arvind Jain w/ Mamoon Hamid: New Playbook

#168 CEO & Founder Glean, Arvind Jain w/ Mamoon Hamid: New Playbook

Guest: Arvind Jain, Founder and CEO of Glean, and Mamoon Hamid, partner at Kleiner Perkins“I’m an engineer, so I have doubts about everything,” says Glean founder and CEO Arvind Jain. Well ... almost ...

11 Joulu 202345min

#167 CEO StockX, Scott Cutler: Detroit’s First Unicorn

#167 CEO StockX, Scott Cutler: Detroit’s First Unicorn

Guest: Scott Cutler, CEO of StockXWhat’s the point of climbing a mountain, or heli-skiing in the Swiss Alps, or biking in the Tour de France? StockX CEO Scott Cutler has done all three, and for him, t...

4 Joulu 202355min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
rss-rahapodi
mimmit-sijoittaa
rss-lahtijat
rahapuhetta
rss-porssipuhetta
rss-neuvottelija-sami-miettinen
rss-rahamania
rss-paasipodi
rss-porssipodi
ostan-asuntoja-podcast
oppimisen-psykologia
rss-strategian-seurassa
rss-h-asselmoilanen
rss-bisnesta-bebeja
rss-merja-mahkan-rahat
rss-inderes
rss-40-ajatusta-aanesta
rss-draivi